Share Capital and Other Equity Instruments (Tables)

12 Months Ended

Dec. 31, 2020

Equity [Abstract]

Schedule of Stock Options

	Number of Shares			Weighted Average Exercise Price (USD)		Weighted Average Grant Date Fair Value (USD)		Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value (USD)
Outstanding – January 1, 2019		689,832		$	1.94	$	1.94
Granted		448,713		$	1.99	$	1.49
Expired, forfeited, or cancelled		(341,172	)	$	1.99	$	0.36
Outstanding – December 31, 2019		797,373		$	1.99	$	0.72
Granted		378,800		$	0.94	$	5.22
Expired forfeited, or cancelled		(246,408	)	$	1.94	$	0.88
Outstanding – December 31, 2020		929,765		$	1.53	$	2.50		6.1	$	2,537,245
Exercisable at December 31, 2020		929,765		$	1.53	$	2.50		6.1	$	2,537,245

Schedule of Fair Value Assumption of Stock Option

The Company utilized the Black-Scholes option-pricing model to determine the fair value of these stock options, using the assumptions as outlined below.

Stock Price	$	5.92
Dividend Yield		0	%
Expected Volatility		84.7	%
Weighted Average Risk-Free Interest Rate		0.37	%
Expected life (in years)		1.5 – 4.2

Schedule of Warrants

The following table summarizes information about shares issuable under warrants outstanding at December 31, 2020:

	Warrant shares outstanding			Weighted average exercise price (USD)			Weighted average remaining life		Intrinsic value
Outstanding at January 1, 2019		219,510		$	2.95			0.08
Issued		84,381		$	3.21
Outstanding at December 31, 2019		303,891		$	3.02			1.06	$	-
Issued		3,222,331		$	1.96
Forfeited		(274,816	)	$	(3.00	)
Outstanding at December 31, 2020		3,251,406		$	1.95			4.97	$	-
Exercisable at December 31, 2020		3,251,406		$	1.95			4.97	$	8,040,545